12:00 AM
Oct 26, 2009
 |  BC Week In Review  |  Company News  |  Deals

DiscoveRx, Evotec deal

Evotec received a non-exclusive license to DiscoveRx's PathHunter and cAMPHunter cell lines and enzyme fragment complementation...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >